Dayton Misfeldt
Overview
Dayton Misfeldt received an average of $457K in total compensation at Sunesis Pharmaceuticals between 2018 and 2019.
Source: SEC filing on April 28, 2020.
Related executives
We found 14 more executives who work or worked at Sunesis Pharmaceuticals.
Ivor Royston
Sunesis Pharmaceuticals
Chief Executive Officer
Lisa Rojkjaer
Sunesis Pharmaceuticals
Chief Medical Officer
Daniel Chevallard
Sunesis Pharmaceuticals
Chief Financial Officer
Par Hyare
Sunesis Pharmaceuticals
Chief Executive Officer
Judith Fox
Sunesis Pharmaceuticals
Chief Scientific Officer
William Quinn
Sunesis Pharmaceuticals
Chief Financial Officer
Daniel Swisher
Sunesis Pharmaceuticals
Chief Executive Officer
Eric Bjerkholt
Sunesis Pharmaceuticals